Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use

A technology of coenzyme and yeast cells, applied in the field of medicine, can solve the problems of the scope of influence, inactivation of coenzyme, degradation and destruction, etc.
CN1586502AActive Publication Date: 2005-03-02北京奥路特生物医药研发有限公司 +2
0 Cites 17 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
北京奥路特生物医药研发有限公司
Publication Date
2005-03-02

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The present invention belongs to the field of medicine technology. The compound coenzyme medicine contains CoA, NAD, GSH and ATP; and features that it contains also FMN, FAD, ADP, AMP and SAM. The present invention has improved compound coenzyme medicine preparing process. The compound coenzyme medicine can protect liver cell, myocardial cell and other cells, maintain or restore their normal metabolism, and may be used in heart and liver surgical operation, restoring of damaged liver, restoring damaged cell caused by radiotherapy and chemotherapy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field

[0001] The invention belongs to the technical field of medicine, and particularly relates to a new preparation method of a composite coenzyme drug and a new type of composite coenzyme drug and new clinical applications. Background technique

[0002] In the 1970s, a composite coenzyme freeze-dried powder injection for injection was developed. It is extracted from yeast (saccharomyces cerevisiae, edible yeast and Geotrichum candidum) and contains coenzyme A (CoA), coenzyme I (NAD), ATP and The natural coenzyme compound preparation of glutathione. It has been used for the treatment of acute and chronic hepatitis, primary thrombocytopenic purpura, thrombocytopenia for a long time, and can be used as adjuvant therapy for coronary atherosclerosis, chronic arteritis, myocardial infarction, oliguria and uremia caused by renal failure.

[0003] Yeast is a single-celled eukaryotic organism, and its cells contain various coenzymes necessary for the metabolism (synthesis and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More